Additional Effects of Kinesio Taping on Knee Joint Proprioception and Spatiotemporal Gait Parameters in Patient With Chrondromalacia Patellae

Chondromalacia patellae (CMP), also known as runner's knee, is characterized by anterior knee pain (AKP) and typically occurs in youngsters. Causes of chondromalacia patellae include micro trauma wear and tear, post traumatic injuries and muscular imbalance. In Chondromalacia patella pain is behind or around the patella caused by stress in the patellofemoral joint that usually provoked by climbing stairs, squatting, and sitting with flexed knees for longer time periods. Patients of CMP presents with patellar mal-tracking, muscular weakness, proprioceptive deficit. Exercise training has been proven beneficial for CMP patients but additive effect of kinesio taping along with exercise have not been seen yet in these patients. The study will help people with chondromalacia patellae to improve their quality of life. The findings will contribute to future research in chondromalacia patellae management.

Study Overview

• Status: Active, not recruiting
• Conditions: Chondromalacia
• Intervention / Treatment: Diagnostic test: Conventional physical therapy; Other: Kinesiotaping

• Study Type: Interventional
• Enrollment (Estimated): 46
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Pakistan
  • Rawalpindi, Pakistan, 46000
    • Foundation University College of Physical Therapy

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Both genders
• Age: Under 60yrs
• Pain while stair climbing, kneeling, squatting, changing position from sitting to standing and running

Exclusive criteria:

• Instability of tibiofemoral joint
• Subluxation of patellofemoral joint
• Patellar instability
• Previous surgery of lower limb
• Positive findings on examination of knee ligaments, menisci and bursa.

Exclusion Criteria:

-

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Conventional physical therapy (exercise therapy) group; Group A will receive this conventional physical therapy protocol for chondromalacia patellae; they will perform stretches to warm up and cool down. Resistance training ,in which patient will perform each exercise for 3 sets of 10 repetitions. Each repetition will be given with a 10 second hold.; Frequency: 3 times a week for 4 weeks.	Diagnostic test: Conventional physical therapy; Conventional physical therapy protocol for chondromalacia patellae consist of stretches to warm up and cool down Resistance training ,in which patient will perform each exercise for 3 sets of 10 repetitions. Each repetition will be given with a 10 second hold.
Experimental: Kinesio taping + Conventional physical therapy group; Group B will be given kinesio taping with conventional physical therapy protocol for chondromalacia patellae. .Kinesio tape will be applied on Vastus medialis Oblique and around the patella. • Frequency: 3 times a week for 4 weeks. They will perform stretches to warm up and cool down. Resistance training ,in which patient will perform each exercise for 3 sets of 10 repetitions. Each repetition will be given with a 10 second hold. Frequency: 3 times a week for 4 weeks.	Diagnostic test: Conventional physical therapy; Conventional physical therapy protocol for chondromalacia patellae consist of stretches to warm up and cool down Resistance training ,in which patient will perform each exercise for 3 sets of 10 repetitions. Each repetition will be given with a 10 second hold.; Other: Kinesiotaping; Kinesio tape will be applied on Vastus medialis Oblique and around the patella. • Frequency: 3 times a week for 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Proprioception	Proprioception will be measured using goniometer.	4 weeks
Pain intensity	Pain will be measured using numeric pain rating scale (NPRS) It is a self-rated scale where patient rate their pain from 0-10. 0 shows no pain where 10 shows worst pain.	4 weeks
Functional status	Functional status is assessed by lower extremity functional scale LEFS. The LEFS is scored on a scale of 0 to 80, with higher scores indicating better lower limb function. The interpretation of the scores is based on following categories. 0-20 Severe Functional limitation.21-40 moderate functional limitation and 41 and above is good functional status.	4 weeks
Gait Speed	Gait analysis will be done to analyze speed.. A greater speed signifies positive outcome and prognosis. Speed = distance(m) x time(s)	4 Weeks
Gait cadence	Gait analysis will be done to analyze cadence. A greater cadence signifies positive outcome and prognosis. Cadence(steps/min) = steps countedx60/ time(s)	4 Weeks
Gait cycle time	Gait analysis will be done to analyze cycle time. A greater cycle time signifies positive outcome and prognosis. Cycle time(s)=time(s) x2/steps counted	4 weeks
Stride length	Gait analysis will be done to analyze stride length. A greater stride length signifies positive outcome and prognosis. Stride Length(m)=Speed(m/s)xcycle time(s)	4 weeks

Collaborators and Investigators

• Sponsor: Foundation University Islamabad

Study record dates

Study Major Dates

• Study Start (Actual): June 10, 2024
• Primary Completion (Estimated): December 10, 2024
• Study Completion (Estimated): December 30, 2024

Study Registration Dates

• First Submitted: July 30, 2024
• First Submitted That Met QC Criteria: August 19, 2024
• First Posted (Actual): August 20, 2024

Study Record Updates

• Last Update Posted (Actual): August 20, 2024
• Last Update Submitted That Met QC Criteria: August 19, 2024
• Last Verified: July 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Musculoskeletal Diseases; Connective Tissue Diseases; Cartilage Diseases
• Other Study ID Numbers: FUI/CTR/2024/20

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No